Tran, Phuong T.
Nduaguba, Sabina O.
Diaby, Vakaramoko
Choi, Yoonyoung
Winterstein, Almut G.
Funding for this research was provided by:
Merck
Article History
Received: 14 March 2022
Accepted: 25 July 2022
First Online: 8 August 2022
Declarations
:
: This study involved de-identified, aggregate data and was not subject to Institutional Review Board approval at University of Florida. All methods were performed in accordance with the relevant guidelines and regulations by IBM® MarketScan® (ExternalRef removed).
: Not applicable.
: Almut Winterstein has received research funding from NIH, AHRQ, PCORI, FDA and the state of Florida and received honoraria as a consultant for Arbor Pharmaceuticals and Genentech Inc, none of which is related to this work. Yoonyoung Choi is an employee at Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.